Zobrazeno 1 - 10 of 2 535 pro vyhledávání: '"Guzman, CA"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Mucosal vaccination with outer membrane vesicles derived from Bordetella pertussis reduces nasal bacterial colonization after experimental infection.
Autor: Rudi E; Laboratorio VacSal, Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CCT-CONICET La Plata, La Plata, Argentina., Gaillard E; Laboratorio VacSal, Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CCT-CONICET La Plata, La Plata, Argentina., Bottero D; Laboratorio VacSal, Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CCT-CONICET La Plata, La Plata, Argentina., Ebensen T; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Guzman CA; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Hozbor D; Laboratorio VacSal, Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CCT-CONICET La Plata, La Plata, Argentina.
Publikováno v: Frontiers in immunology [Front Immunol] 2024 Nov 28; Vol. 15, pp. 1506638. Date of Electronic Publication: 2024 Nov 28 (Print Publication: 2024).
Zobrazit plný text záznamu
4
Akademický článek
Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice.
Autor: Valdes I; Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31, P.O. Box 6162, Havana 6 10 600, Cuba. Electronic address: iris.valdes@cigb.edu.cu., Suzarte E; Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31, P.O. Box 6162, Havana 6 10 600, Cuba., Lazo L; Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31, P.O. Box 6162, Havana 6 10 600, Cuba., Cobas K; Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31, P.O. Box 6162, Havana 6 10 600, Cuba., Cabrales A; Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31, P.O. Box 6162, Havana 6 10 600, Cuba., Pérez Y; Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31, P.O. Box 6162, Havana 6 10 600, Cuba., Garateix R; Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31, P.O. Box 6162, Havana 6 10 600, Cuba., Silva JA; Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31, P.O. Box 6162, Havana 6 10 600, Cuba., Aguilar JC; Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31, P.O. Box 6162, Havana 6 10 600, Cuba., Guzman CA; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Germany., Guillén G; Center for Genetic Engineering and Biotechnology (CIGB), Avenue 31, P.O. Box 6162, Havana 6 10 600, Cuba.
Publikováno v: Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126213. Date of Electronic Publication: 2024 Aug 12.
Zobrazit plný text záznamu
5
Akademický článek
Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses.
Autor: Uno N; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.; Department of Infection Biology, Lehner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Ebensen T; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Guzman CA; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.; Department of Infection Biology, Lehner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Florida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, Florida, USA.; Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.
Publikováno v: Journal of virology [J Virol] 2024 Sep 17; Vol. 98 (9), pp. e0035424. Date of Electronic Publication: 2024 Aug 22.
Zobrazit plný text záznamu
6
Akademický článek
Fast-Track Discovery of SARS-CoV-2-Neutralizing Antibodies from Human B Cells by Direct Functional Screening.
Autor: Hillenbrand M; Memo Therapeutics AG, 8952 Schlieren, Switzerland., Esslinger C; Memo Therapeutics AG, 8952 Schlieren, Switzerland., Seidenberg J; Memo Therapeutics AG, 8952 Schlieren, Switzerland., Weber M; Memo Therapeutics AG, 8952 Schlieren, Switzerland., Zingg A; Memo Therapeutics AG, 8952 Schlieren, Switzerland., Townsend C; Memo Therapeutics AG, 8952 Schlieren, Switzerland., Eicher B; Memo Therapeutics AG, 8952 Schlieren, Switzerland., Rutkauskaite J; Memo Therapeutics AG, 8952 Schlieren, Switzerland., Riese P; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany., Guzman CA; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany., Fischer K; Memo Therapeutics AG, 8952 Schlieren, Switzerland., Schmitt S; Memo Therapeutics AG, 8952 Schlieren, Switzerland.
Publikováno v: Viruses [Viruses] 2024 Feb 22; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 22.
Zobrazit plný text záznamu
8
Akademický článek
Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact.
Autor: Jungbluth S; European Vaccine Initiative (EVI), Heidelberg, 69115, Germany., Martin W; European Vaccine Initiative (EVI), Heidelberg, 69115, Germany., Slezak M; European Vaccine Initiative (EVI), Heidelberg, 69115, Germany., Depraetere H; European Vaccine Initiative (EVI), Heidelberg, 69115, Germany., Guzman CA; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Braunschweig, 38124, Germany., Ussi A; EATRIS- European Research Infrastructure for Translational Medicine, Amsterdam, 1081 HZ, The Netherlands., Morrow D; EATRIS- European Research Infrastructure for Translational Medicine, Amsterdam, 1081 HZ, The Netherlands., Van Heuverswyn F; Flanders Vaccine, Diepenbeek, 3590, Belgium., Arnouts S; provaxs - Ghent University, Merelbeke, 9820, Belgium., Carrondo MJT; iBET - Instituto de Biologia Experimental e Tecnológica, Oeiras, 2781-901, Portugal., Olesen O; European Vaccine Initiative (EVI), Heidelberg, 69115, Germany., Ottenhoff THM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, 2300RC, The Netherlands., Dockrell HM; London School of Hygiene & Tropical Medicine (LSHTM), London, WC1E 7HT, UK., Ho MM; Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, Hertfordshire, EN6 3QG, UK., Dobly A; Sciensano, Brussels, 1050, Belgium., Christensen D; Statens Serum Institut (SSI), Copenhagen, 2300, Denmark., Segalés J; Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Bellaterra, 08193, Spain., Laurent F; Université François Rabelais de Tours, Centre Val de Loire, UMR1282 ISP, INRAE, Nouzilly, 37380, France., Lantier F; Université François Rabelais de Tours, Centre Val de Loire, UMR1282 ISP, INRAE, Nouzilly, 37380, France., Stockhofe-Zurwieden N; Wageningen Bioveterinary Research, Wageningen University & Research (SWR), Wageningen, 6700 HB, The Netherlands., Morelli F; CIRMMP, Sesto Fiorentino, Florence, 50019, Italy., Langermans JAM; Biomedical Primate Research Centre (BPRC), Rijswijk, 2288 GJ, The Netherlands., Verreck FAW; Biomedical Primate Research Centre (BPRC), Rijswijk, 2288 GJ, The Netherlands., Le Grand R; IDMIT Infrastructure, CEA, Université Paris-Saclay, Inserm, Fontenay-aux-Roses, 92265, Cedex, France., Sloots A; Intravacc, Bilthoven, 3721 MA, The Netherlands., Medaglini D; University of Siena, Siena, 53100, Italy., Lawrenz M; Vaccine Formulation Institute (VFI), Plan-les-Ouates, Geneva, 1228, Switzerland., Collin N; Vaccine Formulation Institute (VFI), Plan-les-Ouates, Geneva, 1228, Switzerland.
Publikováno v: F1000Research [F1000Res] 2023 Oct 24; Vol. 12, pp. 1401. Date of Electronic Publication: 2023 Oct 24 (Print Publication: 2023).
Zobrazit plný text záznamu
9
Akademický článek
T cell repertoire breadth is associated with the number of acute respiratory infections in the LoewenKIDS birth cohort.
Autor: Paschold L; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany., Gottschick C; Interdisciplinary Center for Health Sciences, Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical School of the Martin-Luther University Halle-Wittenberg, Magdeburger Strasse 8, 06112, Halle (Saale), Germany., Langer S; Interdisciplinary Center for Health Sciences, Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical School of the Martin-Luther University Halle-Wittenberg, Magdeburger Strasse 8, 06112, Halle (Saale), Germany., Klee B; Interdisciplinary Center for Health Sciences, Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical School of the Martin-Luther University Halle-Wittenberg, Magdeburger Strasse 8, 06112, Halle (Saale), Germany., Diexer S; Interdisciplinary Center for Health Sciences, Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical School of the Martin-Luther University Halle-Wittenberg, Magdeburger Strasse 8, 06112, Halle (Saale), Germany., Aksentijevich I; Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA., Schultheiß C; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany., Purschke O; Interdisciplinary Center for Health Sciences, Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical School of the Martin-Luther University Halle-Wittenberg, Magdeburger Strasse 8, 06112, Halle (Saale), Germany., Riese P; Department Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 38124, Braunschweig, Germany., Trittel S; Department Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 38124, Braunschweig, Germany., Haase R; Department of Neonatology and Pediatric Intensive Care, Hospital St. Elisabeth und St. Barbara, 06110, Halle (Saale), Germany., Dressler F; Department of Pediatric Pulmonology, Allergology and Neonatology, Hannover Medical School, 30625, Hannover, Germany., Eberl W; Department of Paediatrics, Hospital Braunschweig, 38118, Braunschweig, Germany., Hübner J; Department of Paediatrics, Dr. von Hauner Children's Hospital, Ludwig- Maximilians-University Munich, 80337, Munich, Germany., Strowig T; Department Microbial Immune Regulation, Helmholtz Centre for Infection Research, 38124, Braunschweig, Germany., Guzman CA; Department Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 38124, Braunschweig, Germany., Mikolajczyk R; Interdisciplinary Center for Health Sciences, Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical School of the Martin-Luther University Halle-Wittenberg, Magdeburger Strasse 8, 06112, Halle (Saale), Germany., Binder M; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany. Mascha.Binder@unibas.ch.; Division of Medical Oncology, University Hospital Basel, Petersgraben 4, 40314031, Basel, Switzerland. Mascha.Binder@unibas.ch.
Publikováno v: Scientific reports [Sci Rep] 2023 Jun 12; Vol. 13 (1), pp. 9516. Date of Electronic Publication: 2023 Jun 12.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje